CE Share Price | Celanese Corp. Stock Analysis & Recommendation

Q: What does Celanese Corp. do?

Overview:Celanese Corporation is a technology and specialty materials company operating in the specialty chemicals industry, with a market capitalization in the large-cap bracket.Financial Snapshot:- Net Sales: 2,389 Million (Quarterly Results - Mar 2025)- Net Profit: -12 Million (Quarterly Results - Mar 2025)- Market cap: USD 9,258.74 Million (Large Cap)Key Metrics:- Dividend Yield: 1.72%- Debt Equity: 2.30- Return on Equity: -1.64%- Price to Book: 1.79Contact Details:- Address: 222 Las Colinas Blvd W Ste 900N, IRVING TX: 75039-5467- Tel: ['1 972 4434000', '1 972 4433728']- Fax: 1 302 6555049- Website: https://www.celanese.com/

Q: Is Celanese Corp. overvalued or undervalued?

As of 18 February 2025, the valuation grade for Celanese Corp. has moved from expensive to risky, indicating a shift in perception regarding its market value. Based on the current metrics, Celanese appears to be overvalued, particularly given its high EV to EBITDA ratio of 11.97 and a Price to Book Value of 1.82, which suggest that the stock is trading at a premium relative to its assets. Additionally, the company's return on equity (ROE) is notably negative at -1.64%, further reinforcing concerns about its profitability.In comparison to its peers, Celanese Corp. has a significantly higher P/E ratio of 144.70 compared to Westlake Corp.'s 82.20 and Albemarle Corp.'s -101.94, indicating that investors are paying much more for each dollar of earnings, or in this case, losses. The stock has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -34.29% compared to the index's 12.22%, and a staggering -64.01% over the past year against the S&P 500's 17.14%. This performance further suggests that Celanese is not only overvalued but also struggling significantly in the current market environment.

Q: Is Celanese Corp. technically bullish or bearish?

As of 8 September 2025, the technical trend for Celanese Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by bearish MACD readings on both weekly and monthly time frames, as well as bearish signals from Bollinger Bands and KST. The daily moving averages also reflect a bearish outlook. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating some mixed signals. Dow Theory and OBV show no trend in both weekly and monthly assessments.In terms of performance, Celanese has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -34.29% compared to the S&P's 12.22%, and a one-year return of -64.01% versus the S&P's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.1 M

Shareholding (Dec 2025)

FII

18.98%

Held by 285 FIIs

DII

Held by 113 DIIs

Promoter

0.18%

How big is Celanese Corp.?

22-Jun-2025

As of Jun 18, Celanese Corp. has a market capitalization of 9,258.74 million and reported net sales of 10,058.00 million with a net profit loss of 1,642.00 million for the latest four quarters. As of Dec 24, the company has shareholder's funds of 5,175.00 million and total assets of 22,857.00 million.

View full answer

What does Celanese Corp. do?

22-Jun-2025

Celanese Corporation is a technology and specialty materials company in the specialty chemicals industry, with a market cap of approximately $9.26 billion. As of March 2025, it reported net sales of $2.39 billion and a net profit of -$12 million.

View full answer

Who are in the management team of Celanese Corp.?

22-Jun-2025

As of March 2022, the management team of Celanese Corp. includes Ms. Lori Ryerkerk (Chairman, President, CEO), Mr. Edward Galante (Lead Independent Director), and several independent directors: Ms. Deborah Kissire, Ms. Jean Blackwell, Mr. William Brown, and Ms. Kathryn Hill. They guide the company's strategic direction and oversee operations.

View full answer

Is Celanese Corp. overvalued or undervalued?

20-Sep-2025

As of February 18, 2025, Celanese Corp. is considered risky and overvalued due to its high EV/EBITDA ratio of 11.97, negative ROE of -1.64%, and significantly higher P/E ratio of 144.70 compared to peers, alongside poor stock performance with a year-to-date return of -34.29% versus the S&P 500's 12.22%.

View full answer

Is Celanese Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Celanese Corp. is in a bearish trend with weak strength, indicated by negative MACD readings and underperformance against the S&P 500, showing a year-to-date return of -34.29% compared to the S&P's 12.22%.

View full answer

Compare Celanese Corp. with Similar Stocks

Avantor, Inc.Westlake Corp.Albemarle Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared Negative results for the last 3 consecutive quarters

NET PROFIT(9M) At USD -110 MM has Grown at -110.12%
OPERATING CASH FLOW(Y) Lowest at USD 1,020 MM
ROCE(HY) Lowest at -25.69%

Risky -

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 9,538 Million (Small Cap)

P/E

22.00

Industry P/E

Dividend Yield

0.11%

Debt Equity

2.80

Return on Equity

10.87%

Price to Book

2.36

Revenue and Profits:

Net Sales:

2,204 Million

(Quarterly Results - Dec 2025)

Net Profit:

28 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

32.72%

6 Months

25.22%

1 Year

-2.68%

2 Years

-64.91%

3 Years

-44.71%

4 Years

-60.13%

5 Years

-61.69%

Celanese Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.03%

EBIT Growth (5y)

1.33%

EBIT to Interest (avg)

6.54

Debt to EBITDA (avg)

4.95

Net Debt to Equity (avg)

2.30

Sales to Capital Employed (avg)

0.54

Tax Ratio

42.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

11.64%

ROE (avg)

32.55%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.36

EV to EBIT

27.14

EV to EBITDA

13.57

EV to Capital Employed

1.36

EV to Sales

2.19

PEG Ratio

0.05

Dividend Yield

0.11%

ROCE (Latest)

5.00%

ROE (Latest)

10.87%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 114 Schemes (96.95%)

Foreign Institutions

Held by 285 Foreign Institutions (18.98%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -8.89% vs -4.46% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 102.07% vs -738.21% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,204.00",
          "val2": "2,419.00",
          "chgp": "-8.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "311.00",
          "val2": "419.00",
          "chgp": "-25.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "211.00",
          "val2": "175.00",
          "chgp": "20.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "22.00",
          "val2": "-1,461.00",
          "chgp": "101.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.00",
          "val2": "-1,353.00",
          "chgp": "102.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.60%",
          "val2": "90.10%",
          "chgp": "-3.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.05% vs -6.14% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 25.95% vs -177.34% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,544.00",
          "val2": "10,268.00",
          "chgp": "-7.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,549.00",
          "val2": "1,866.00",
          "chgp": "-16.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "762.00",
          "val2": "669.00",
          "chgp": "13.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,660.00",
          "val2": "-1,674.00",
          "chgp": "0.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,130.00",
          "val2": "-1,526.00",
          "chgp": "25.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "80.90%",
          "val2": "105.50%",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

2,204.00

2,419.00

-8.89%

Operating Profit (PBDIT) excl Other Income

311.00

419.00

-25.78%

Interest

211.00

175.00

20.57%

Exceptional Items

22.00

-1,461.00

101.51%

Consolidate Net Profit

28.00

-1,353.00

102.07%

Operating Profit Margin (Excl OI)

57.60%

90.10%

-3.25%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -8.89% vs -4.46% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 102.07% vs -738.21% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

9,544.00

10,268.00

-7.05%

Operating Profit (PBDIT) excl Other Income

1,549.00

1,866.00

-16.99%

Interest

762.00

669.00

13.90%

Exceptional Items

-1,660.00

-1,674.00

0.84%

Consolidate Net Profit

-1,130.00

-1,526.00

25.95%

Operating Profit Margin (Excl OI)

80.90%

105.50%

-2.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -7.05% vs -6.14% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 25.95% vs -177.34% in Dec 2024

All Annual Results

Company CV

About Celanese Corp.

Celanese Corp.

Specialty Chemicals

Celanese Corporation (Celanese) is a technology and specialty materials company. The Company's segments include Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, Acetyl Intermediates and Other Activities. The Advanced Engineered Materials segment includes the Company's engineered materials business and certain affiliates. The Consumer Specialties segment includes the Company's cellulose derivatives and food ingredients businesses, which serve consumer-driven applications. The Industrial Specialties segment includes the Company's emulsion polymers and ethylene vinyl acetate (EVA) polymers businesses. The Acetyl Intermediates segment includes the Company's intermediate chemistry business, which produces and supplies acetyl products, including acetic acid, vinyl acetate monomer (VAM), acetic anhydride and acetate esters. The Company has operations in North America, Europe and Asia. As of December 31, 2016, the Company had 30 global production facilities.

Company Coordinates

Company Details

222 Las Colinas Blvd W Ste 900N , IRVING TX : 75039-5467

Tel: 1 972 44340001 972 4433728

https://www.celanese.com/

Registrar Details